For instance, N-acetylglucosaminyltransferase III (GnTIII) and GnTV overexpression-modified glycosylation of integrin α3β1 and E-cadherin could induce EMT and cell invasion in GC cells, highlighting that targeting specific glycosylation might have potential in anti-cancer therapy; however, this needs further investigation (Zhao et al., 2006; Pinho et al., 2013). This evidence concerns the gene MGAT3 and cancer.